Showing 1216 Results
NPC’s Westrich to Answer: Have ACO Medication Capabilities Improved?
NPC Vice President of Health Services Research Kimberly Westrich will discuss accountable care organizations’ (ACOs) current abilities in utilizing medications to achieve the best patient health…
NPC’s Dr. Dubois Answers: Are ACOs Ready to Manage Medications?
NPC Chief Science Officer Robert Dubois, MD, PhD, will present recommendations on how to optimally use medications to achieve success in value-based health during a panel at the Value-Based Payment…
National Pharmaceutical Council 2015 Annual Report
NPC had an active 2015, publishing a number of research studies and speaking at conferences about important health topics.
New Study Puts Previous 5 Years of NPC Annual CER Survey Into Perspective
For the last five years, we’ve had our fingers on the pulse of what health care stakeholders are thinking about comparative effectiveness research and its potential impact on health care decision…
What Contributes Most to High Health Care Costs?
A small segment of the population—often the sickest patients—drive the majority of health care spending. This study, which examined the spending patterns for these high resource patients (HRP), …
Care Pathways in U.S. Health Care Settings: Current Successes and Limitations, and Future Challenges
Care pathways, also known as clinical pathways or integrated care pathways, are typically characterized as a method for managing patient care based on clinical practice guidelines, with the main…
#TBT: Moonshot to Cure Cancer & the Importance of Individual Treatment Effects
As part of our Throwback Thursday blog series, we’re taking a look at an issue currently in the news and tagging it with previous research, videos or commentaries in a relevant way. As the saying…
Five Questions About New Health Policy Fellowship Answered
Are you looking for a post-doctoral fellowship in health policy? The National Pharmaceutical Council (NPC) and the University of Southern California’s (USC) Schaeffer Center for Health Policy and…
ASCO’s Clinical Pathways Recommendations and Remaining Challenges
The American Society of Clinical Oncology (ASCO) today released its “policy statement on clinical pathways in oncology,” which acknowledges the challenges in developing these pathways and offers…
Key Considerations for Cost Effectiveness Thresholds
In his latest column in the Journal of Comparative Effectiveness Research (JCER), National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses what broad use of cost…
#TBT: Five Most Popular NPC Blog Posts of 2015
As part of our Throwback Thursday blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way. As the…
FDA/CMS Summit Offers Opportunity to Focus on Value
From the 21st Century Cures Act to negotiations about reauthorizing the Prescription Drug User Fee Act (PDUFA), much of this year has been focused on a range of health care issues—including how to…
Standards and Subgroups: Why it’s Important to Account for Differences Across Patient Groups When Developing Quality Measures
Sue Peschin, president and CEO of the Alliance for Aging Research, noted during a conversation with the National Pharmaceutical Council (NPC), while “it’s always been important for clinicians to be…
Using the GRADE Process to Improve Patient Care: A Practical Experience
Dr. Joel V. Brill, medical director at FAIR Health, Inc., shared his experience working with the American Gastroenterological Association (AGA) on its process for developing guidelines during a video…
For Public Comment: AMCP's Updated Format for Formulary Submissions
The Academy of Managed Care Pharmacy today released for public comment an updated draft version of its Format for Formulary Submissions, a framework that outlines evidence requirements used by…